Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Acetazolamide on the Severity of REM Obstructive Sleep Apnea

NCT05589792 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT05589792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05589792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Acetazolamide on the Severity of REM Obstructive Sleep Apnea
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
January 30, 2023
Completion date
December 31, 2025
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea